Redox proteomics and the dynamic molecular landscape of the aging brain

Ageing Research Reviews

Volumn 13, Issue 1, 2014, Pages 75-89

  Perluigi, Marzia ^a   Swomley, Aaron M ^b   Butterfield, D Allan ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Antioxidants; Caloric restriction; Neurodegeneration; Protein oxidation; Redox proteomics in brain aging; SAMP8

Indexed keywords

ACETIC ACID DERIVATIVE; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN E; CARNITINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; CREATINE KINASE; CYSTEINE; FODRIN; LACTATE DEHYDROGENASE; THIOCTIC ACID; VITAMIN D;

AGING; ALZHEIMER DISEASE; BRAIN; BRAIN AGING; CALORIC RESTRICTION; CANINE MODEL; DIET; DYNAMICS; GENOTYPE; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MURINE MODEL; NERVE DEGENERATION; NITROSYLATION; NONHUMAN; OLFACTORY SYSTEM; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SENESCENCE ACCELERATED MOUSE; UBIQUITINATION;

ANTIOXIDANTS; CALORIC RESTRICTION; NEURODEGENERATION; PROTEIN OXIDATION; REDOX PROTEOMICS IN BRAIN AGING; SAMP8;

AGE FACTORS; AGING; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CALORIC RESTRICTION; DOGS; HUMANS; MICE; MODELS, ANIMAL; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; RATS; TIME FACTORS;

EID: 84892463241     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.12.005     Document Type: Review

References (180)

1. Aksenova M.V., Burbaeva G. BB creatine kinase isoenzyme activity in the blood serum of patients with senile dementia, Alzheimer's disease and schizophrenia. Zh. Nevropatol. Psikh. 1989, 89(9):113-116.
2. Aluise C.D., Robinson R.A., et al. Preclinical Alzheimer disease: brain oxidative stress, Ab peptide, and proteomics. Neurobiol. Dis. 2010, 39:221-228.
3. Aluise C.D., Robinson R.A., et al. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. J. Alzheimers Dis. 2011, 23(2):257-269.
4. Ames B.N., Shigenaga M.K., et al. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(17):7915-7922.
5. Babizhayev M.A., Yegorov Y.E. Reactive oxygen species and the aging eye: specific role of metabolically active mitochondria in maintaining lens function and in the initiation of the oxidation-induced maturity onset cataract-a novel platform of mitochondria-targeted antioxidants with broad therapeutic potential for redox regulation and detoxification of oxidants in eye diseases. Am. J. Ther. 2010.
6. Bader Lange M.L., St Clair D., et al. Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiol. Dis. 2010, 38(1):104-115.
7. Bahr B.A., Vanderklish P.W., et al. Spectrin breakdown products increase with age in telencephalon of mouse brain. Neurosci. Lett. 1991, 131(2):237-240.
8. Bookheimer S., Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu. Rev. Clin. Psychol. 2009, 5:343-362.
9. Boutte A.M., Woltjer R.L., et al. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. FASEB J. 2006, 20(9):1473-1483.
10. Boyd-Kimball D., Sultana R., et al. Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach. J. Neurosci. Res. 2005, 79(5):707-713.
11. Broniowska K.A., Hogg N. The chemical biology of S-nitrosothiols. Antioxid. Redox Signal. 2012, 17(7):969-980.
12. Butterfield D., Castegna A., et al. Nutritional approaches to combat oxidative stress in Alzheimer's disease. J. Nutr. Biochem. 2002, 13(8):444-461.
13. Butterfield D.A. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 1997, 10(5):495-506.
14. Butterfield D.A., Drake J., et al. Evidence of oxidative damage in Alzheimer's disease brain. Trends Mol. Med. 2001, 7:548-554.
15. Butterfield D.A., Galvan V., et al. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic. Biol. Med. 2010, 48(1):136-144.
16. Butterfield D.A., Howard B.J., et al. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(2):674-678.
17. Butterfield D.A., Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 2001, 122(9):945-962.
18. Butterfield D.A., Lange M.L. Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J. Neurochem. 2009, 111(4):915-933.
19. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 2002, 32(11):1050-1060.
20. Butterfield D.A., Perluigi M., et al. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid. Redox Signal. 2012, 17(11):1610-1655.
21. Butterfield D.A., Perluigi M., et al. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 2006, 545(1):39-50.
22. Butterfield D.A., Poon H.F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp. Gerontol. 2005, 40(10):774-783.
23. Butterfield D.A., Poon H.F., et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis. 2006, 22(2):223-232.
24. Butterfield D.A., Reed T.T., et al. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res. 2007, 1148:243-248.
25. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 1997, 2:161-191.
26. Butterfield D.A., Sultana R. Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders. Expert Rev. Proteomics 2008, 5(2):157-160.
27. Butterfield D.A., Sultana R. Methionine-35 of abeta(1-42): importance for oxidative stress in Alzheimer disease. J. Amino Acids 2011, 2011:198430.
28. Cai Y., Zhu H.X., et al. Age-related intraneuronal elevation of alphaII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3xTg-AD mice. PLoS ONE 2012, 7(6):e37599.
29. Calabrese V., Butterfield D.A., et al. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem. 2003, 52(4):177-181.
30. Calabrese V., Cornelius C., et al. Vitagenes, cellular stress response, and acetylcarnitine: relevance to hormesis. Biofactors 2009, 35(2):146-160.
31. Calabrese V., Cornelius C., et al. Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol. Biol. 2010, 610:285-308.
32. Calabrese V., Scapagnini G., et al. Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech. Ageing Dev. 2004, 125(4):325-335.
33. Castegna A., Aksenov M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 2002, 33(4):562-571.
34. Castorina M., Ferraris L. Acetyl-l-carnitine affects aged brain receptorial system in rodents. Life Sci. 1994, 54(17):1205-1214.
35. Chance B., Sies H., et al. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979, 59(3):527-605.
36. Chandrasekaran K., Giordano T., et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res. 1994, 24(1-4):336-340.
37. Chinta S.J., Rajagopalan S., et al. In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's disease. Neurosci. Lett. 2006, 402(1-2):137-141.
38. Choi Y.B., Tenneti L., et al. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci. 2000, 3(1):15-21.
39. Coleman P.D., Flood D.G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 1987, 8(6):521-545.
40. Corbisier P., Remacle J. Involvement of mitochondria in cell degeneration. Eur. J. Cell Biol. 1990, 51(1):173-182.
41. Cummings B.J., Head E., et al. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol. Learn. Mem. 1996, 66(1):11-23.
42. Cummings B.J., Head E., et al. The canine as an animal model of human aging and dementia. Neurobiol. Aging 1996, 17(2):259-268.
43. David S., Shoemaker M., et al. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Res. Mol. Brain Res. 1998, 54(2):276-287.
44. De la Fuente M., Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr. Pharm. Des. 2009, 15(26):3003-3026.
45. DeKroon R.M., Osorio C., et al. Simultaneous detection of changes in protein expression and oxidative modification as a function of age and APOE genotype. J. Proteome Res. 2011, 10(4):1632-1644.
46. Di Domenico F., Coccia R., et al. Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. Biochim. Biophys. Acta 2011, 1814(12):1785-1795.
47. Di Domenico F., Coccia R., et al. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain. Biochim. Biophys. Acta 2013, 1832(8):1249-1259.
48. Dremina E.S., Sharov V.S., et al. Protein tyrosine nitration in rat brain is associated with raft proteins, flotillin-1 and alpha-tubulin: effect of biological aging. J. Neurochem. 2005, 93(5):1262-1271.
49. Dubey A., Forster M.J., et al. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch. Biochem. Biophys. 1996, 333(1):189-197.
50. Economou A., Papageorgiou S.G., et al. Nonepisodic memory deficits in amnestic MCI. Cogn. Behav. Neurol. 2007, 20(2):99-106.
51. Esterbauer H., Schaur R.J., et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11(1):81-128.
52. Farr S.A., Poon H.F., et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. 2003, 84(5):1173-1183.
53. Farr S.A., Ripley J.L., et al. Antisense oligonucleotide against GSK-3ß in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer Disease. Free Radic. Biol. Med. 2013, (in press). 10.1016/j.freeradbiomed.
54. Felten D.L., Felten S.Y., et al. Age-related decline in the dopaminergic nigrostriatal system: the oxidative hypothesis and protective strategies. Ann. Neurol. 1992, 32(Suppl.):S133-S136.
55. Fiorini A., Sultana R., et al. Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study. Free Radic. Biol. Med. 2013, 65:1-14.
56. Flood J.F., Morley J.E. Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol. Aging 1993, 14(2):153-157.
57. Fortuno A., San Jose G., et al. Oxidative stress and vascular remodelling. Exp. Physiol. 2005, 90(4):457-462.
58. Fugere N.A., Ferrington D.A., et al. Protein nitration with aging in the rat semimembranosus and soleus muscles. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61(8):806-812.
59. Gelinas S., Chapados C., et al. Effect of oxidative stress on stability and structure of neurofilament proteins. Biochem. Cell Biol. 2000, 78(6):667-674.
60. Getchell T.V., Krishna N.S., et al. Human olfactory receptor neurons express heat shock protein 70: age-related trends. Ann. Otol. Rhinol. Laryngol. 1995, 104(1):47-56.
61. Giordano G., White C.C., et al. Assessment of glutathione homeostasis. Methods Mol. Biol. 2011, 758:205-214.
62. Gokulrangan G., Zaidi A., et al. Proteomic analysis of protein nitration in rat cerebellum: effect of biological aging. J. Neurochem. 2007, 100(6):1494-1504.
63. Grillari J., Katinger H., et al. Aging and the ubiquitinome: traditional and non-traditional functions of ubiquitin in aging cells and tissues. Exp. Gerontol. 2006, 41(11):1067-1079.
64. Grimsrud P.A., Xie H., et al. Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 2008, 283(32):21837-21841.
65. Grune T., Merker K., et al. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 2003, 305(3):709-718.
66. Grune T., Reinheckel T., et al. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 1996, 271(26):15504-15509.
67. Guerrieri F., Vendemiale G., et al. Alteration of mitochondrial F0F1 ATP synthase during aging. Possible involvement of oxygen free radicals. Ann. N. Y. Acad. Sci. 1996, 786:62-71.
68. Guo Z., Ersoz A., et al. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J. Neurochem. 2000, 75(1):314-320.
69. Hagen T.M. Oxidative stress, redox imbalance, and the aging process. Antioxid. Redox Signal. 2003, 5(5):503-506.
70. Halliwell B., Gutteridge J.W. Free Radical Biology and Medicine 1984, Oxford University Press, Oxford, UK.
71. Harada J., Sugimoto M. Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons. Brain Res. 1999, 842(2):311-323.
72. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11(3):298-300.
73. Harman D. Aging: overview. Ann. N. Y. Acad. Sci. 2001, 928:1-21.
74. Haynes V., Traaseth N.J., et al. Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am. J. Physiol. Endocrinol. Metab. 2010, 298(5):E978-E987.
75. Head E. A canine model of human aging and Alzheimer's disease. Biochim. Biophys. Acta 2013, 1832(9):1384-1389.
76. Head E., McCleary R., et al. Region-specific age at onset of beta-amyloid in dogs. Neurobiol. Aging 2000, 21(1):89-96.
77. Hensley K., Venkova K., et al. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 2011, 43(3):180-191.
78. Hoffman P.N., Cleveland D.W., et al. Neurofilament gene expression: a major determinant of axonal caliber. Proc. Natl. Acad. Sci. U. S. A. 1987, 84(10):3472-3476.
79. Huang Q., Aluise C.D., et al. Potential in vivo amelioration by N-acetyl-l-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. J. Neurosci. Res. 2010, 88(12):2618-2629.
80. Ingram D.K., Weindruch R., et al. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 1987, 42(1):78-81.
81. Joshi G., Hardas S., et al. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: implication for chemobrain. J. Neurosci. Res. 2007, 85(3):497-503.
82. Kawamata T., Akiguchi I., et al. Age-related changes in the brains of senescence-accelerated mice (SAM): association with glial and endothelial reactions. Microsc. Res. Tech. 1998, 43(1):59-67.
83. Keeney J.T., Forster S., et al. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline. Free Radic. Biol. Med. 2013, 65C:324-334.
84. Klein W.L. Synaptic targeting by A beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease. Alzheimers Dement. 2006, 2(1):43-55.
85. Korotchkina L.G., Yang H., et al. Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 2001, 30(9):992-999.
86. Koubova J., Guarente L. How does calorie restriction work?. Genes Dev. 2003, 17(3):313-321.
87. Kregel K.C., Zhang H.J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292(1):R18-R36.
88. Kumar V.B., Farr S.A., et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 2000, 21(12):1769-1775.
89. Kuo Y.M., Kokjohn T.A., et al. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J. Biol. Chem. 2001, 276(16):12991-12998.
90. Lass A., Sohal B.H., et al. Caloric restriction prevents age-associated accrual of oxidative damage to mouse skeletal muscle mitochondria. Free Radic. Biol. Med. 1998, 25(9):1089-1097.
91. Leto T.L., Fortugno-Erikson D., et al. Comparison of nonerythroid alpha-spectrin genes reveals strict homology among diverse species. Mol. Cell. Biol. 1988, 8(1):1-9.
92. Levine R.L. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic. Biol. Med. 2002, 32(9):790-796.
93. Levine R.L., Williams J.A., et al. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994, 233:346-357.
94. Lopez-Sanchez L.M., Corrales F.J., et al. Alteration of S-nitrosothiol homeostasis and targets for protein S-nitrosation in human hepatocytes. Proteomics 2008, 8(22):4709-4720.
95. Lovell M.A., Xie C., et al. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22(2):187-194.
96. Lu T., Finkel T. Free radicals and senescence. Exp. Cell Res. 2008, 314(9):1918-1922.
97. Lushchak V.I., Bahnjukova T.V., et al. Effect of hypoxia on the activity and binding of glycolytic and associated enzymes in sea scorpion tissues. Braz. J. Med. Biol. Res. 1998, 31(8):1059-1067.
98. Madamanchi N.R., Vendrov A., et al. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25(1):29-38.
99. Maekawa M., Sudo K., et al. Analysis of a genetic mutation in an electrophoretic variant of the human lactate dehydrogenase-B(H) subunit. Hum. Genet. 1993, 91(5):423-426.
100. Mancuso C., Scapagini G., et al. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci. 2007, 12:1107-1123.
101. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 2000, 1(2):120-129.
102. Mattson M.P. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res. 2000, 886(1-2):47-53.
103. Meier-Ruge W., Iwangoff P., et al. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 1984, 3(2):161-165.
104. Mesholam R.I., Moberg P.J., et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch. Neurol. 1998, 55(1):84-90.
105. Milgram N.W., Zicker S.C., et al. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol. Aging 2002, 23(5):737-745.
106. Miquel J., Economos A.C., et al. Mitochondrial role in cell aging. Exp. Gerontol. 1980, 15(6):575-591.
107. Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp. Gerontol. 1997, 32(1-2):139-148.
108. Moreira P.I., Smith M.A., et al. Oxidative stress and neurodegeneration. Ann. N. Y. Acad. Sci. 2005, 1043:545-552.
109. Morley J.E., Kumar V.B., et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000, 21(12):1761-1767.
110. Morrow J.D., Roberts J.D. Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress. Meth. Mol. Biol. 2002, 186:57-66.
111. Moskovitz J., Bar-Noy S., et al. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(23):12920-12925.
112. Moskovitz J., Flescher E., et al. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(24):14071-14075.
113. Moskovitz J., Maiti P., et al. Induction of methionine-sulfoxide reductases protects neurons from amyloid beta-protein insults in vitro and in vivo. Biochemistry 2011, 50(49):10687-10697.
114. Murphy C., Schubert C.R., et al. Prevalence of olfactory impairment in older adults. JAMA 2002, 288(18):2307-2312.
115. Nomura Y., Yamanaka Y., et al. Senescence-accelerated mouse. Neurochemical studies on aging. Ann. N. Y. Acad. Sci. 1996, 786:410-418.
116. Nunomura A., Moreira P.I., et al. Oxidative damage to RNA in aging and neurodegenerative disorders. Neurochem. Res. 2012, 22(3):231-248.
117. Ohta A., Hirano T., et al. Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res. 1989, 498(1):195-198.
118. Oien D.B., Moskovitz J. Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr. Top. Dev. Biol. 2008, 80:93-133.
119. Okabe S., Miyasaka H., et al. Dynamics of the neuronal intermediate filaments. J. Cell Biol. 1993, 121(2):375-386.
120. Okatani Y., Wakatsuki A., et al. Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse. Neurobiol. Aging 2002, 23(4):639-644.
121. Opii W.O., Joshi G., et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol. Aging 2008, 29(1):51-70.
122. Packer L., Roy S., et al. Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv. Pharmacol. 1997, 38:79-101.
123. Perkins A.J., Hendrie H.C., et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 1999, 150(1):37-44.
124. Perluigi M., Coccia R., et al. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid. Redox Signal. 2012, 17(11):1590-1609.
125. Perluigi M., Di Domenico F., et al. Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J. Neurosci. Res. 2010, 88(16):3498-3507.
126. Perrig W.J., Perrig P., et al. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 1997, 45(6):718-724.
127. Perry G., Nunomura A., et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?. Free Radic. Biol. Med. 2002, 33(11):1475-1479.
128. Pocernich C.B., Butterfield D.A. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim. Biophys. Acta 2012, 1822(5):625-630.
129. Poon H.F., Calabrese V., et al. Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by l-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid. Redox Signal. 2006, 8(3-4):381-394.
130. Poon H.F., Castegna A., et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 2004, 126(4):915-926.
131. Poon H.F., Farr S.A., et al. Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res. Mol. Brain Res. 2005, 138(1):8-16.
132. Poon H.F., Joshi G., et al. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 2004, 1018(1):86-96.
133. Poon H.F., Shepherd H.M., et al. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 2006, 27(7):1020-1034.
134. Poon H.F., Vaishnav R.A., et al. Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes. J. Neurochem. 2005, 94(2):380-392.
135. Raju K., Doulias P.T., et al. Strategies and tools to explore protein S-nitrosylation. Biochim. Biophys. Acta 2012, 1820(6):684-688.
136. Rebrin I., Kamzalov S., et al. Effects of age and caloric restriction on glutathione redox state in mice. Free Radic. Biol. Med. 2003, 35(6):626-635.
137. Riederer I.M., Schiffrin M., et al. Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease. Brain Res. Bull. 2009, 80(4-5):233-241.
138. Rinaldi P., Polidori M.C., et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24(7):915-919.
139. Sakai I., Sharief F.S., et al. The cDNA and protein sequences of human lactate dehydrogenase B. Biochem. J. 1987, 248(3):933-936.
140. Santos R.X., Correia S.C., et al. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease. Free Radic. Res. 2012, 46(4):565-576.
141. Sayre L.M., Zelasko D.A., et al. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997, 68(5):2092-2097.
142. Scheff S.W., Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 2003, 24(8):1029-1046.
143. Schurr A., Payne R.S., et al. Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J. Neurochem. 1997, 69(1):423-426.
144. Selkoe D.J., Bell D.S., et al. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 1987, 235(4791):873-877.
145. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
146. Seth D., Stamler J.S. The SNO-proteome: causation and classifications. Curr. Opin. Chem. Biol. 2011, 15(1):129-136.
147. Shahani N., Sawa A. Nitric oxide signaling and nitrosative stress in neurons: role for S-nitrosylation. Antioxid. Redox Signal. 2011, 14(8):1493-1504.
148. Sharov V.S., Ferrington D.A., et al. Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase. FEBS Lett. 1999, 455(3):247-250.
149. Shimano Y. Studies on aging through analysis of the glucose metabolism related to the ATP-production of the senescence accelerated mouse (SAM). Hokkaido Igaku Zasshi 1998, 73(6):557-569.
150. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997, 82(2):291-295.
151. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10(3):319-329.
152. Smith C.D., Carney J.M., et al. Protein oxidation in aging brain. Ann. N. Y. Acad. Sci. 1992, 663:110-119.
153. Sohal R.S., Sohal B.H. Hydrogen peroxide release by mitochondria increases during aging. Mech. Ageing Dev. 1991, 57(2):187-202.
154. Spiteller G. The important role of lipid peroxidation processes in aging and age dependent diseases. Mol. Biotechnol. 2007, 37(1):5-12.
155. St-Pierre J., Buckingham J.A., et al. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002, 277(47):44784-44790.
156. Stadtman E.R. Protein oxidation and aging. Free Radic. Res. 2006, 40(12):1250-1258.
157. Stadtman E.R., Levine R.L. Protein oxidation. Ann. N. Y. Acad. Sci. 2000, 899:191-208.
158. Stamler J.S., Simon D.I., et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(1):444-448.
159. Subramaniam R., Roediger F., et al. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem. 1997, 69(3):1161-1169.
160. Suh J.H., Moreau R., et al. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 2005, 10(1):52-60.
161. Suh J.H., Wang H., et al. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 2004, 423(1):126-135.
162. Sultana R., Boyd-Kimball D., et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol. Aging 2006, 27(11):1564-1576.
163. Sultana R., Butterfield D.A. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 2004, 29(12):2215-2220.
164. Sultana R., Butterfield D.A. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. J. Alzheimers Dis. 2013, 33(Suppl. 1):S243L 251.
165. Sultana R., Robinson R.A., et al. Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh)×PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. J. Proteomics 2011, 74(11):2430-2440.
166. Suzuki Y.J., Carini M., et al. Protein carbonylation. Antioxid. Redox Signal. 2010, 12(3):323-325.
167. Takeda T., Hosokawa M., et al. A new murine model of accelerated senescence. Mech. Ageing Dev. 1981, 17(2):183-194.
168. Terman A., Brunk U.T. Aging as a catabolic malfunction. Int. J. Biochem. Cell Biol. 2004, 36(12):2365-2375.
169. Texel S.J., Mattson M.P. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid. Redox Signal. 2011, 14(8):1519-1534.
170. Thal D.R., Rub U., et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58(12):1791-1800.
171. Thal L.J., Calvani M., et al. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology 2000, 55(6):805-810.
172. Toda T., Nakamura M., et al. Proteomic approaches to oxidative protein modifications implicated in the mechanism of aging. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S25-S31.
173. Toussaint O., Royer V., et al. Stress-induced premature senescence and tissue ageing. Biochem. Pharmacol. 2002, 64(5-6):1007-1009.
174. Varadarajan S., Yatin S., et al. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Res. Bull. 1999, 50(2):133-141.
175. Vigneron A., Vousden K.H. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2010, 2(8):471-474.
176. Weitzdoerfer R., Fountoulakis M., et al. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. J. Neural Transm. Suppl. 2001, 61:95-107.
177. Yagi H., Katoh S., et al. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res. 1988, 474(1):86-93.
178. Yoshida H., Watanabe A., et al. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. J. Biol. Chem. 1998, 273(16):9761-9768.
179. Zahid S., Khan R., et al. Differential S-nitrosylation of proteins in Alzheimer's disease. Neuroscience 2013.
180. Zhu Y., Carvey P.M., et al. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006, 1090(1):35-44.